Mi az ára Bioasis Technologies Inc. (BTI)

Bioasis Technologies Inc. (BTI) ára $0.00366968

Mi a Bioasis Technologies Inc. (BTI piaci tőkésítése)

Bioasis Technologies Inc. piaci tőkésítése (BTI) $291.42K

Bioasis Technologies Inc. (BTI) Ár és Piaci Kapitalizáció

Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused on innovating diagnostic methods and therapeutic solutions for a range of neurological conditions. The company's primary technological asset is the xB3 platform, engineered to enable the transport of medicinal compounds across the often-impenetrable blood-brain barrier. This capability is crucial for addressing central nervous system disorders, including various brain cancers, metabolic dysfunctions, and neurodegenerative illnesses. Bioasis is actively advancing its in-house pipeline with programs such as xB3-001 for brain metastases, xB3-002 for glioblastoma, and xB3-007 for neurodegenerative diseases, all designed to offer both symptomatic relief and disease-modifying benefits. The company has also established numerous strategic alliances. These include a partnership with Aposense Limited to deliver siRNA therapeutics for CNS disorders; a collaboration with Oxyrane UK Ltd. to combine the xB3 technology with Oxyrane's OxyCAT platform for enhanced enzyme replacement therapy targeting the brain; an agreement with Janssen Biotech, Inc. for the discovery, development, and commercialization of novel products leveraging the xB3 platform; and a research and licensing deal with Neuramedy Co Ltd. to develop and market an xB3-enhanced version of their antibody, Tomaralimab. Founded in 2006, Bioasis Technologies Inc. is headquartered in New Haven, Connecticut.

A BTI ára	B aktíva	A B piaci tőkésítése	Eredmények
$68,873.72 $291.42K	NVDA	$5.470T	+1,876,829,455.54%
$56,250.42 $291.42K	AAPL	$4.467T	+1,532,840,809.29%
$52,564.87 $291.42K	GOOG	$4.174T	+1,432,408,272.84%
$46,592.25 $291.42K	MSFT	$3.700T	+1,269,652,791.00%
$35,942.56 $291.42K	AMZN	$2.854T	+979,445,505.37%

A BTI ára

B aktíva

A B piaci tőkésítése

Eredmények

$68,873.72 $291.42K